This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Weintraub WS, Goeree R, Zhang Z, Teo K, Kolm P, Spertus JA, Maron D, O'Rourke R, Hartigan P, Culler S, Becker E, Boden WE, Barnett PG, COURAGE Investigators.Cost effectiveness of adding PCI to optimal medical therapy in patients with stable coronary artery disease: economic outcomes from the COURAGE trial. Circulation 116: 794, No. 16, 16 Oct 2007
Rights and permissions
About this article
Cite this article
Added angioplasty of no value in stable CAD. Pharmacoecon. Outcomes News 541, 14 (2007). https://doi.org/10.2165/00151234-200705410-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705410-00023